295 related articles for article (PubMed ID: 7492989)
21. Improvement of impaired glucose tolerance by oral administration of vanadyl sulfate by gavage in streptozotocin-induced diabetic rats.
Tsunajima T; Tatsuki R; Satoh K; Yamamoto A; Hoshi K; Ichihara K
Res Commun Mol Pathol Pharmacol; 1997 Nov; 98(2):190-200. PubMed ID: 9467827
[TBL] [Abstract][Full Text] [Related]
22. In vivo antidiabetic actions of naglivan, an organic vanadyl compound in streptozotocin-induced diabetes.
Cam MC; Cros GH; Serrano JJ; Lazaro R; McNeill JH
Diabetes Res Clin Pract; 1993 May; 20(2):111-21. PubMed ID: 8375263
[TBL] [Abstract][Full Text] [Related]
23. Vanadyl ion suppresses nitric oxide production from peritoneal macrophages of streptozotocin-induced diabetic mice.
Tsuji A; Sakurai H
Biochem Biophys Res Commun; 1996 Sep; 226(2):506-11. PubMed ID: 8806664
[TBL] [Abstract][Full Text] [Related]
24. DNA cleavage by hydroxyl radicals generated in a vanadyl ion-hydrogen peroxide system.
Sakurai H; Nakai M; Miki T; Tsuchiya K; Takada J; Matsushita R
Biochem Biophys Res Commun; 1992 Dec; 189(2):1090-5. PubMed ID: 1365812
[TBL] [Abstract][Full Text] [Related]
25. Oxidovanadium(IV) Schiff base complex derived from vitamin B6: synthesis, characterization, and insulin enhancing properties.
Mukherjee T; Costa Pessoa J; Kumar A; Sarkar AR
Inorg Chem; 2011 May; 50(10):4349-61. PubMed ID: 21495653
[TBL] [Abstract][Full Text] [Related]
26. A new halogenated antidiabetic vanadyl complex, bis(5-iodopicolinato)oxovanadium(IV): in vitro and in vivo insulinomimetic evaluations and metallokinetic analysis.
Takino T; Yasui H; Yoshitake A; Hamajima Y; Matsushita R; Takada J; Sakurai H
J Biol Inorg Chem; 2001 Feb; 6(2):133-42. PubMed ID: 11293406
[TBL] [Abstract][Full Text] [Related]
27. Effects of vanadium (III, IV, V)-chlorodipicolinate on glycolysis and antioxidant status in the liver of STZ-induced diabetic rats.
Xie M; Chen D; Zhang F; Willsky GR; Crans DC; Ding W
J Inorg Biochem; 2014 Jul; 136():47-56. PubMed ID: 24747360
[TBL] [Abstract][Full Text] [Related]
28. Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats.
Reul BA; Amin SS; Buchet JP; Ongemba LN; Crans DC; Brichard SM
Br J Pharmacol; 1999 Jan; 126(2):467-77. PubMed ID: 10077240
[TBL] [Abstract][Full Text] [Related]
29. Protective effect of vanadyl sulfate on the pancreas of streptozotocin-induced diabetic rats.
Bolkent S; Bolkent S; Yanardag R; Tunali S
Diabetes Res Clin Pract; 2005 Nov; 70(2):103-9. PubMed ID: 16188572
[TBL] [Abstract][Full Text] [Related]
30. Oral vanadyl sulfate in treatment of diabetes mellitus in rats.
Ramanadham S; Mongold JJ; Brownsey RW; Cros GH; McNeill JH
Am J Physiol; 1989 Sep; 257(3 Pt 2):H904-11. PubMed ID: 2675634
[TBL] [Abstract][Full Text] [Related]
31. Effects of some vanadyl coordination compounds on the in vitro insulin release from rat pancreatic islets.
Conconi MT; DeCarlo E; Vigolo S; Grandi C; Bandoli G; Sicolo N; Tamagno G; Parnigotto PP; Nussdorfer GG
Horm Metab Res; 2003 Jul; 35(7):402-6. PubMed ID: 12931270
[TBL] [Abstract][Full Text] [Related]
32. Long-term effects of vanadyl treatment on streptozocin-induced diabetes in rats.
Pederson RA; Ramanadham S; Buchan AM; McNeill JH
Diabetes; 1989 Nov; 38(11):1390-5. PubMed ID: 2695373
[TBL] [Abstract][Full Text] [Related]
33. A new insulin-mimetic vanadyl complex, (N-pyridylmethylaspartate)oxovanadium(IV) with VO(N2O2) coordination mode, and evaluation of its effect on uptake of D-glucose by Ehrlich ascites tumour cells.
Tawa R; Uchida K; Taniyama J; Fujisawa Y; Fujimoto S; Nagaoka T; Kanamori K; Sakurai H
J Pharm Pharmacol; 1999 Feb; 51(2):119-24. PubMed ID: 10217308
[TBL] [Abstract][Full Text] [Related]
34. Effect of insulin-mimetic vanadyl sulfate on cytochrome P450 2E1-dependent p-nitrophenol hydroxylation in the liver microsomes of streptozotocin-induced type 1 diabetic rats.
Kataoka S; Yasui H; Hiromura M; Sakurai H
Life Sci; 2005 Oct; 77(22):2814-29. PubMed ID: 15964029
[TBL] [Abstract][Full Text] [Related]
35. Effects of vanadyl sulfate on kidney in experimental diabetes.
Yanardag R; Bolkent S; Karabulut-Bulan O; Tunali S
Biol Trace Elem Res; 2003 Oct; 95(1):73-85. PubMed ID: 14555801
[TBL] [Abstract][Full Text] [Related]
36. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
[TBL] [Abstract][Full Text] [Related]
37. Vanadium and diabetes.
Poucheret P; Verma S; Grynpas MD; McNeill JH
Mol Cell Biochem; 1998 Nov; 188(1-2):73-80. PubMed ID: 9823013
[TBL] [Abstract][Full Text] [Related]
38. Conformation changes in brain calcineurin in diabetic rats with or without treatment with vanadyl sulfate.
Li H; Wei Q
IUBMB Life; 2001 Jun; 51(6):373-6. PubMed ID: 11758805
[TBL] [Abstract][Full Text] [Related]
39. Effects of vanadyl sulphate on glucose homeostasis in severe diabetes induced by streptozotocin in rats.
Dehghani GA; Ahmadi S; Omrani GR
Indian J Med Res; 1997 Nov; 106():481-5. PubMed ID: 9415745
[TBL] [Abstract][Full Text] [Related]
40. Diabetes-altered gene expression in rat skeletal muscle corrected by oral administration of vanadyl sulfate.
Willsky GR; Chi LH; Liang Y; Gaile DP; Hu Z; Crans DC
Physiol Genomics; 2006 Aug; 26(3):192-201. PubMed ID: 16684804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]